Skip to main content
Clinical Trials/CTRI/2021/09/036462
CTRI/2021/09/036462
Not yet recruiting
Phase 4

To Evaluate The Therapeutic Efficacy Of Intranasal Tapentadol In Pain Management In Opioid Use Disorder

GMC RH Patiala0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: F112- Opioid dependence
Sponsor
GMC RH Patiala
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
GMC RH Patiala

Eligibility Criteria

Inclusion Criteria

  • 1\.Male and female patients aged 18\-65 years with ICD\-10 diagnosis of Opioid Dependence.
  • 2\.Patients who will bw mdeically stable.
  • 3\.Patients who have given written informed consent.

Exclusion Criteria

  • 1\. History of chronic psychosis or drug induced psychosis of any kind.
  • 2\. Patients with paralytic ileus and respiratory depression.
  • 3\. Pregnant women, lactating mothers, surgically\-sterile women or women who agree to continue using applicable birth control throughout the trial. All women of child\-bearing potential must have a negative urine pregnancy test.
  • 4\. History of seizures, renal insufficiency or congestive heart failure.
  • 5\. History of ketamine abuse/dependence or prior clinically significant adverse reaction to ketamine.

Outcomes

Primary Outcomes

Not specified

Similar Trials